Analyzing data from nearly 150,000 children with prenatal antidepressant exposure in two healthcare databases, a recent study finds no association between prenatal exposure to antidepressants and risk for neurodevelopmental disorders.
While questions and controversies remain, the information on long-term neurodevelopmental outcomes in children prenatally exposed to antidepressants is largely reassuring.
Despite decreasing rates of alcohol and tobacco use during pregnancy, the use of cannabis use during pregnancy is on the rise. We are seeing an increasing number of women in our clinic who are using [...]
While some women with bipolar disorder elect to discontinue their psychotropic medications during pregnancy to mitigate fetal exposure, Viguera and colleagues (2000, 2007) found that women stabilized on lithium face a significant risk for [...]
We have long been interested in understanding the effects of prenatal exposure to antidepressants on the development of the fetal brain. The earliest studies addressing this question were small but yielded detailed (and reassuring) information [...]
Over the years, various studies have demonstrated the many advantages of breastfeeding, findings that have led the American Academy of Pediatrics to recommend that all mothers breastfeed their children for the first year of the [...]
Many studies have documented the finding that exposure to maternal psychiatric illness early on in the child’s life may adversely affect the child’s cognitive, emotional and behavioral development. These early studies focused on the impact [...]
The research of Lynne Murray and Peter Cooper in the 1990s was pivotal in terms of demonstrating the negative effects of postpartum depression on the cognitive development of young children and played an important role [...]
